Nek1 silencing slows down DNA repair and blocks DNA damage-induced cell cycle arrest. 2010

Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
Department of Biophysics, Federal University of Rio Grande do Sul, Avenida Bento Gonçalves, 9500, Porto Alegre, RS, Brazil.

Never in mitosis A (NIMA)-related kinases (Nek) are evolutionarily conserved proteins structurally related to the Aspergillus nidulans mitotic regulator NIMA. Nek1 is one of the 11 isoforms of the Neks identified in mammals. Different lines of evidence suggest the participation of Nek1 in response to DNA damage, which is also supported by the interaction of this kinase with proteins involved in DNA repair pathways and cell cycle regulation. In this report, we show that cells with Nek1 knockdown (KD) through stable RNA interference present a delay in DNA repair when treated with methyl-methanesulfonate (MMS), hydrogen peroxide (H(2)O(2)) and cisplatin (CPT). In particular, interstrand cross links induced by CPT take much longer to be resolved in Nek1 KD cells when compared to wild-type (WT) cells. In KD cells, phosphorylation of Chk1 in response to CPT was strongly reduced. While WT cells accumulate in G(2)/M after DNA damage with MMS and H(2)O(2), Nek1 KD cells do not arrest, suggesting that G(2)/M arrest induced by the DNA damage requires Nek1. Surprisingly, CPT-treated Nek1 KD cells arrest with a 4N DNA content similar to WT cells. This deregulation in cell cycle control in Nek1 KD cells leads to an increased sensitivity to genotoxic agents when compared to WT cells. These results suggest that Nek1 is involved in the beginning of the cellular response to genotoxic stress and plays an important role in preventing cell death induced by DNA damage.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries

Related Publications

Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
March 2013, Journal of neuroscience research,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
February 2018, The EMBO journal,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
December 1999, Carcinogenesis,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
January 1994, Trends in cell biology,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
February 2010, Apoptosis : an international journal on programmed cell death,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
September 2018, Scientific reports,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
March 2016, Scientific reports,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
October 2015, Acta biochimica et biophysica Sinica,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
September 2013, Environmental toxicology and pharmacology,
Alessandra Luíza Pelegrini, and Dinara Jaqueline Moura, and Bethânia Luise Brenner, and Pitia Flores Ledur, and Gabriela Porto Maques, and João Antônio Pegas Henriques, and Jenifer Saffi, and Guido Lenz
December 1999, Oncogene,
Copied contents to your clipboard!